or Try an Advanced Search...

    Technical Analysis for IDYA - IDEAYA Biosciences, Inc.

    Grade Last Price % Change Price Change
    F 25.99 1.76% 0.45
    IDYA closed down 1.24 percent on Wednesday, November 20, 2024, on 65 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical IDYA trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 1.76%
    NR7 Range Contraction 1.76%
    NR7-2 Range Contraction 1.76%
    Narrow Range Bar Range Contraction 1.76%
    Lower Bollinger Band Walk Weakness 1.76%
    New 52 Week Low Weakness 1.76%
    Below Lower BB Weakness 1.76%
    Down 3 Days in a Row Weakness 1.76%
    Down 4 Days in a Row Weakness 1.76%
    Down 5 Days in a Row Weakness 1.76%
    Older End-of-Day Signals for IDYA ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout 9 minutes ago
    Fell Below Previous Day's Low about 1 hour ago
    Down 1% about 1 hour ago
    New 52 Week Low about 1 hour ago
    Rose Above Lower Bollinger Band about 1 hour ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    IDYA Chart by TradingView
    Basic chart:

    Profile

    IDEAYA is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with small molecule drug discovery to select patient populations most likely to benefit from the targeted therapies IDEAYA is developing. IDEAYA is applying these capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality – which represents an emerging class of precision medicine targets.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Clinical Medicine Drug Discovery Medical Genetics Medical Test Biomarkers Precision Medicine Molecular Diagnostics Targeted Therapy Systems Biology Synthetic Lethality

    Is IDYA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer
    Nov 15 Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It
    Nov 12 IDEAYA Biosciences Announces Participation in Jefferies London Healthcare Conference and Plans for Investor R&D Day
    Nov 11 IDEAYA Announces Development Candidate Nomination of IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise with Biocytogen
    Nov 11 Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise
    Nov 7 Wall Street Analysts Predict an 81.88% Upside in IDEAYA Biosciences (IDYA): Here's What You Should Know
    Nov 5 IDEAYA Biosciences Third Quarter 2024 Earnings: US$0.60 loss per share (vs US$0.46 loss in 3Q 2023)
    Nov 4 /C O R R E C T I O N -- IDEAYA Biosciences, Inc./
    Nov 4 IDEAYA Biosciences GAAP EPS of -$0.60 beats by $0.04
    Nov 1 IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    See more IDYA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 47.735
    52 Week Low 25.35
    Average Volume 838,728
    200-Day Moving Average 38.19
    50-Day Moving Average 30.79
    20-Day Moving Average 29.15
    10-Day Moving Average 28.84
    Average True Range 1.43
    RSI (14) 31.03
    ADX 22.28
    +DI 18.82
    -DI 35.77
    Chandelier Exit (Long, 3 ATRs) 28.39
    Chandelier Exit (Short, 3 ATRs) 29.63
    Upper Bollinger Bands 32.69
    Lower Bollinger Band 25.61
    Percent B (%b) -0.01
    BandWidth 24.27
    MACD Line -1.17
    MACD Signal Line -0.75
    MACD Histogram -0.4151
    Fundamentals Value
    Market Cap 1.84 Billion
    Num Shares 72.1 Million
    EPS -1.98
    Price-to-Earnings (P/E) Ratio -12.90
    Price-to-Sales 140.95
    Price-to-Book 6.52
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 26.59
    Resistance 3 (R3) 26.64 26.35 26.42
    Resistance 2 (R2) 26.35 26.08 26.32 26.36
    Resistance 1 (R1) 25.94 25.91 25.80 25.89 26.30
    Pivot Point 25.65 25.65 25.57 25.62 25.65
    Support 1 (S1) 25.24 25.38 25.10 25.19 24.78
    Support 2 (S2) 24.95 25.21 24.92 24.72
    Support 3 (S3) 24.54 24.95 24.67
    Support 4 (S4) 24.49